4//SEC Filing
Yang Arvin 4
Accession 0001104659-22-005547
CIK 0001442836other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:59 PM ET
Size
8.4 KB
Accession
0001104659-22-005547
Insider Transaction Report
Form 4
Yang Arvin
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2022-01-14+28,333→ 28,333 total→ Common Stock (28,333 underlying) - Award
Stock Option (right to buy)
2022-01-14+127,500→ 127,500 totalExercise: $6.28Exp: 2032-01-13→ Common Stock (127,500 underlying)
Holdings
- 12,973
Common Stock
Footnotes (3)
- [F1]The option vests in equal quarterly installments over the first four years after the vesting commencement date, January 14, 2022.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F3]The restricted stock units vest in equal annual installments over the first four years after the vesting commencement date, January 14, 2022.
Documents
Issuer
Mersana Therapeutics, Inc.
CIK 0001442836
Entity typeother
Related Parties
1- filerCIK 0001834321
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 5:59 PM ET
- Size
- 8.4 KB